Drug Trial Radar · NCT04982445
Study Using CABENUVA™ for the Treatment of Human Immunodeficiency Virus (HIV)-1, Administered in Infusion Centers (IC) or Alternate Sites of Administration (ASA) in the United States (U.S.)
Last checked: Nov 20, 2026Latest source record: Apr 1, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
44
Actual
Start
Nov 18, 2021
Primary completion
Jan 31, 2024
Study completion Jan 31, 2024
Sponsor
- Lead sponsor
- ViiV HealthcareGSK (GSK)
- Sponsor type
- Industry
- First posted
- Jul 29, 2021
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
GLACIER (Giving Long Acting CABENUVA in an Infusion center/ASA) is an interventional study examining the administration of CABENUVA (Cabotegravir long acting \[LA\] plus Rilpivirine LA) intramuscular (IM) in infusion centers/ASAs in United States. In this study, the intervention is the process of using an infusion center/ASA as the location to receive the CABENUVA IM injections. The acceptability and feasibility of the IC/ASA to deliver CABENUVA IM injections will be assessed from the perspectives of the participants, HIV care providers and IC/ASA staff. In this study, Month 1 is the Baseline visit. CABENUVA is a registered trademark of ViiV Healthcare.
Conditions
- HIV Infections
Interventions
CABENUVADrug
CABENUVA will be administered IM at infusion centers/ASAs
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants Who Agree or Completely Agree (a Score of 4 or Higher) Across All Items on the Feasibility of Intervention Measure (FIM)Time frame: At Month 8
Locations
15 sites in 1 country. Site status is shown where the registry gives one.
GSK Investigational Site
Evans, Georgia
GSK Investigational Site
East Lansing, Michigan
GSK Investigational Site
Novi, Michigan
GSK Investigational Site
Plymouth, Minnesota
GSK Investigational Site
Charlotte, North Carolina
GSK Investigational Site
Greensboro, North Carolina
GSK Investigational Site
Raleigh, North Carolina
GSK Investigational Site
Charleston, South Carolina
GSK Investigational Site
Florence, South Carolina
GSK Investigational Site
Summerville, South Carolina
GSK Investigational Site
West Columbia, South Carolina
GSK Investigational Site
Fort Worth, Texas
GSK Investigational Site
Kingwood, Texas
GSK Investigational Site
North Richland Hills, Texas
GSK Investigational Site
Plano, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.